-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Zingibroside R1
Category | Human immunodeficiency Virus (HIV) |
CAS | 80930-74-1 |
Description | Zingibroside R1 is a triterpenoid showing anti-tumor, anti-angiogenic and anti-HIV-1 activity. |
Product Information
Synonyms | Ginsenoside Z-R1; 28-O-deglucosyl-chikusetsusaponin V |
Molecular Weight | 795 |
Molecular Formula | C42H66O14 |
Canonical SMILES | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C)C2C1)C)C(=O)O)C |
InChI | InChI=1S/C42H66O14/c1-37(2)14-16-42(36(51)52)17-15-40(6)20(21(42)18-37)8-9-24-39(5)12-11-25(38(3,4)23(39)10-13-41(24,40)7)54-35-32(29(47)28(46)31(55-35)33(49)50)56-34-30(48)27(45)26(44)22(19-43)53-34/h8,21-32,34-35,43-48H,9-19H2,1-7H3,(H,49,50)(H,51,52)/t21-,22+,23-,24+,25-,26+,27-,28-,29-,30+,31-,32+,34-,35+,39-,40+,41+,42-/m0/s1 |
InChIKey | WJQOMUVKRDJBGZ-COUNGWPASA-N |
Purity | 0.98 |
Density | 1.37±0.1 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Powder |
Storage | 4°C, protect from light * In solvent : -80°C, 6 months -20°C, 1 month (protect from light) |
Complexity | 1560 |
Exact Mass | 794.44525677 |
PSA | 232.90000 |
Target | IC50: 91.3 μM (2-DG uptake) |
XLogP3-AA | 4.5 |